STABILIZED OPHTHALMIC GALACTOMANNAN FORMULATIONS
The present invention relates to viscosity stabilized ophthalmic formulations and ophthalmic formulations suitable for drug delivery. The formulations comprise galactomannans such as guar or hydroxypropyl guar and a borate source such as boric acid. The formulations further comprise a diol alcohol s...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
28.12.2012
|
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention relates to viscosity stabilized ophthalmic formulations and ophthalmic formulations suitable for drug delivery. The formulations comprise galactomannans such as guar or hydroxypropyl guar and a borate source such as boric acid. The formulations further comprise a diol alcohol such as sorbitol and, optionally, a pharmaceutically acceptable divalent cation salt such as magnesium chloride. |
---|---|
AbstractList | The present invention relates to viscosity stabilized ophthalmic formulations and ophthalmic formulations suitable for drug delivery. The formulations comprise galactomannans such as guar or hydroxypropyl guar and a borate source such as boric acid. The formulations further comprise a diol alcohol such as sorbitol and, optionally, a pharmaceutically acceptable divalent cation salt such as magnesium chloride. |
Author | KETELSON, HOWARD, ALLEN MEADOWS, DAVID, L DAVIS, JAMES, W |
Author_xml | – fullname: KETELSON, HOWARD, ALLEN – fullname: DAVIS, JAMES, W – fullname: MEADOWS, DAVID, L |
BookMark | eNrjYmDJy89L5WQwCA5xdPL08YxydVHwD_AI8XD08fV0VnB39HF0DvH3dfTzc_RTcPMP8g31cQzx9PcL5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8cHuhhamJkZGjobGhFUAALF5J5w |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | SG185422A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_SG185422A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:12:08 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_SG185422A13 |
Notes | Application Number: SG20120081386 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20121228&DB=EPODOC&CC=SG&NR=185422A1 |
ParticipantIDs | epo_espacenet_SG185422A1 |
PublicationCentury | 2000 |
PublicationDate | 20121228 |
PublicationDateYYYYMMDD | 2012-12-28 |
PublicationDate_xml | – month: 12 year: 2012 text: 20121228 day: 28 |
PublicationDecade | 2010 |
PublicationYear | 2012 |
RelatedCompanies | ALCON RESEARCH, LTD |
RelatedCompanies_xml | – name: ALCON RESEARCH, LTD |
Score | 2.8797688 |
Snippet | The present invention relates to viscosity stabilized ophthalmic formulations and ophthalmic formulations suitable for drug delivery. The formulations comprise... |
SourceID | epo |
SourceType | Open Access Repository |
Title | STABILIZED OPHTHALMIC GALACTOMANNAN FORMULATIONS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20121228&DB=EPODOC&locale=&CC=SG&NR=185422A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3JTsMwEB1VBQE3KKCWNQeUW0XjJnVyqJCzF2WpSIoqLlW2Ci6lokH8PmOTApfeLFsa2yPN8uxZAO5KhFtGxj9Z85IiQFGKfj7UR_2CUEVZkooaoiVLGI38mfo41-YteN3mwog6oV-iOCJKVIHyXgt9vf57xLJFbOXmPn_DqfcHNx3bcoOOFVTERJdtc-xMYzu2ZMsaJ54cPaGQayohDHHSHneieZV959nkOSnr_wbFPYb9KdJa1SfQqlYdOLS2fdc6cBA23904bCRvcwqDJGXmJJi8OLYUT_3UZwEyUPJYwKw0DlkUsUhCRBfOgp_M4DO4dZ3U8vu49eL3lovE255xeA5txP5Vl2dUD6laEJJpg5K7Dpli6BlFI6xlOl3SrAfdXVQudi9dwhHnFY_KIPoVtOuPz-oabWud3wi2fAMiAXi0 |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8JAEJ4QNOJNUYNPejC9EenSsuVAzNK39hVbDPFCtqVEL0ikxr_vdC3qhdtmN5ndnWRm9tt5AdwuEG6NeOVkzRYUAYqS97KBPuzlhCrKkhR0JFqyBOHQnaoPM23WgNdtLoyoE_oliiOiROUo76XQ1-u_TyxTxFZu7rI3nHq_t9OxKdfoWEFFTHTZnIytODIjQzaMceLI4RMKuaYSwhAn7VEEhAIoPU-qnJT1f4NiH8F-jLRW5TE0ilUbWsa271obDoLa3Y3DWvI2J9BPUjbxfO_FMqUodlOX-chAyWE-M9IoYGHIQgkRXTD1fzKDT6FrW6nh9nDr-e8t54mzPePgDJqI_YtOlVE9oGpOCNf6i-rpwJWRzikaYY3rdEn5OXR2UbnYvdSFlpsG_tz3wsdLOKz4VkVoEP0KmuXHZ3GNdrbMbgSLvgHrgHue |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=STABILIZED+OPHTHALMIC+GALACTOMANNAN+FORMULATIONS&rft.inventor=KETELSON%2C+HOWARD%2C+ALLEN&rft.inventor=DAVIS%2C+JAMES%2C+W&rft.inventor=MEADOWS%2C+DAVID%2C+L&rft.date=2012-12-28&rft.externalDBID=A1&rft.externalDocID=SG185422A1 |